Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens

BACKGROUND AND PURPOSE: Varenicline, a neuronal nicotinic acetylcholine receptor (nAChR) modulator, decreases ethanol consumption in rodents and humans. The proposed mechanism of action for varenicline to reduce ethanol consumption has been through modulation of dopamine (DA) release in the nucleus...

Descripción completa

Detalles Bibliográficos
Autores principales: Feduccia, A A, Simms, J A, Mill, D, Yi, H Y, Bartlett, S E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105930/
https://www.ncbi.nlm.nih.gov/pubmed/24628360
http://dx.doi.org/10.1111/bph.12690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105930/
https://www.ncbi.nlm.nih.gov/pubmed/24628360
http://dx.doi.org/10.1111/bph.12690

Ejemplares similares